BioGrid Australia facilitates collaborative medical and bioinformatics research across hospitals and medical research institutes by linking data from diverse disease and data types

Human Mutation

Volumn 32, Issue 5, 2011, Pages 517-525

  Merriel, Robert B ^a,b   Gibbs, Peter ^a,b,c   O'Brien, Terence J ^a,d   Hibbert, Marienne ^d,e  

^a MELBOURNE HEALTH   (Australia)

^b BioGrid Australia   (Australia)

^c OLIVIA NEWTON JOHN CANCER RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e Victorian Partnership for Advanced Computing   (Australia)

Author keywords

ACCORD; Bio21; BioGrid; Bioinformatics; Data linkage; MMIM; Molecular Medicine Informatics Model

Indexed keywords

ARTICLE; AUSTRALIA; BIOINFORMATICS; COMPUTER SECURITY; DATA ANALYSIS; DATA EXTRACTION; ENDOCRINE DISEASE; ETHICS; GOVERNMENT REGULATION; HEALTH SERVICE; HISTOPATHOLOGY; HOSPITAL; HUMAN; INTERNET; MEDICAL INFORMATICS; MEDICAL INFORMATION SYSTEM; MEDICAL RECORD; MEDICAL RESEARCH; MEDICAL TECHNOLOGIST; NEOPLASM; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PRIVACY; RESPIRATORY TRACT DISEASE; STANDARD;

ACADEMIES AND INSTITUTES; AUSTRALIA; BIOMEDICAL RESEARCH; COMPUTATIONAL BIOLOGY; COMPUTER SECURITY; COOPERATIVE BEHAVIOR; DATA COLLECTION; DATABASES, FACTUAL; HUMANS; PRIVACY;

EID: 79955014662     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.21437     Document Type: Article

References (8)

1. Cotton RGH, Axton M, Bankier A, Brais B, Cavedon L, du Sart D, George P, Goldgar D, Harrison T, Hibbert M, Hopper J, Macrae F, O'Keefe CM, Ravine D, Savarirayan R, Sheffield L, Smith T, Stokes N, Sundararajan V, Thorburn D, Winship I. The Human Variome Project: Suggested Actions from the Melbourne Information Seminar Nature Proceedings: doi:10.1038/npre.2008.1784.2: Posted 11 April 2008.
2. Jones SG, O'Brien TJ, Adams SJ, Mocellin R, Kilpatrick CJ, Yerra R, Lloyd JH, Velakoulis D. 2010. Clinical characteristics and outcome in patients with psychogenic non-epileptic seizures. Psychosomatic Medicine 72:487-497.
3. Lane JM, Chow E, Young GP, Good N, Smith A, Bull J, Sandford J, Morcom JM, Bampton PA, Cole SR. 2010. Interval fecal immunochemical testing in a colonoscopic surveillance program for increased risk for colorectal cancer. Gastroenterology (in Press).
4. Petrovski S, Szoeke CEI, Jones NC, Salzberg MR, Sheffield LJ, Huggins RM, O'Brien TJ. 2010. Pre-Treatment Patient-Perceived Neurocognitive Symptomatology Predicts Seizure Recurrence in Newly Treated Patients. Neurology 75:1015-1021.
5. Petrovski S, Szoeke CEI, Sheffield LJ, D'Souza W, Huggins R, O'Brien TJ. 2009. A multi-SNP pharmacogenomic classifier is superior to single SNP models for predicting drug outcome in complex diseases. Pharmacogenetics and Genomics 19:147-152.
6. Szoeke C, Sills GJ, Kwan P, Petrovski S, Newton M, Hitiris N, Baum L, Berkovic SF, Brodie MJ, Sheffield L, O'Brien TJ. 2009. Multidrug resistant (ABCB1) Genotype & Seizure Recurrence in Newly Treated Epilepsy: Data from International Pharmacogenetic Cohorts. Epilepsia 50:1689-1696.
7. Walterfang M, Siu R, Velakoulis D. 2006. Establish the validity and reliability of a cognitive-or brain function tool. MMINM has computerised and using NUCOG and incorporating the data. Aust N Z J Psychiatry 40:995-1002.
8. Wong C, Gibbs P, Johns J, Jones I, Faragher I, Lynch E, Macrae F, Lipton L. 2008. Value of database linkage: are patients at risk of familial colorectal cancer being referred for genetic counseling and testing? IMJ 38:328-333.